Core Viewpoint - The "Data Element × Medical Security" competition held in Zhuhai focuses on enhancing the management level of medical data and improving the convenience of medical insurance services through data empowerment in the healthcare sector [1][2]. Group 1: Event Overview - The Guangdong division of the "Data Element ×" competition featured a "Medical Security" track, guided by the Guangdong Provincial Government and various local authorities, with a focus on driving data empowerment across multiple industries [1]. - The competition included 10 teams that presented projects aimed at improving medical data management and enhancing medical insurance services [1]. Group 2: Project Highlights - The project by Guoxin Health Insurance Service Co., Ltd. introduced a "data-driven, technology-enabled" model for intelligent supervision of medical insurance funds, achieving a 70% accuracy rate in identifying high-risk operations [2]. - The "Cloud Medical Insurance Prescription Data Element Empowerment Supervision Platform" by Qiyi Tianxia Big Data Technology aims to break down data barriers in healthcare, covering 17 medical institutions and 258 pharmacies in Zhuhai, with a prescription turnover exceeding 500 million yuan over five years [2]. Group 3: Expert Insights - Zhang Lei, a judge from Sun Yat-sen University, emphasized the importance of separating medical and insurance aspects in the competition, highlighting the use of AI and big data for effective management of medical insurance funds [2]. - Zhang also noted that digital tools for medical insurance should be continuously improved to balance the workload of doctors and policy feedback, promoting sustainable development for hospitals and rational use of insurance funds [2].

As filed with the U.S. Securities and Exchange Commission on September 12, 2025 Registration No. 333-288932 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Wellgistics Health, Inc. (Exact name of registrant as specified in its charter.) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Delaware 8090 93-3264234 (IRS Employer Identification No.) 3000 Bayport Dri ...

Core Insights - HealthLynked Corp. has submitted two new U.S. patent applications to enhance its intellectual property portfolio in patient-centric healthcare technology, focusing on secure medical record access, appointment scheduling, and AI-driven care management [1][4] Patent Applications - The first patent application is for a Universal Patient Identifier (UPIN), which creates a unique medical record identifier without using Social Security numbers, thereby enhancing security and connectivity across electronic medical record platforms [2] - The second patent application is for an AI Appointment Scheduling Agent, which is a multilingual system that books appointments while considering a patient's medical history and preferences, improving the scheduling experience for patients and reducing administrative burdens for providers [3] Company Vision and Strategy - The CEO of HealthLynked emphasized that these patent filings align with the company's long-term vision to transform patient engagement in healthcare, leveraging AI to create a secure and connected healthcare network [4] - HealthLynked aims to empower patients with secure access to their health data, streamline care coordination, and reduce healthcare costs through technology-driven efficiency [4][5] Company Overview - HealthLynked Corp. enhances healthcare through personalized care management, connecting patients with providers for virtual or in-office appointments, and consolidating medical records into a secure, accessible location [5] - The company utilizes AI-driven insights and integrated telehealth services to improve care coordination and deliver savings on prescriptions and healthcare services [6]

Core Insights - Homecare Homebase (HCHB) has partnered with Element5 to enhance operational efficiency for healthcare providers by integrating Element5's Agentic AI platform with HCHB's EHR system [1][4] - The collaboration aims to address challenges in post-acute care, such as Medicare Advantage growth, staffing shortages, slim margins, and regulatory burdens [2][4] - The integration of intelligent agents from Element5 allows for the automation of complex processes, leading to reduced operational costs and improved workflows [3][4] Group 1 - The partnership combines HCHB's workflow knowledge with Element5's AI capabilities to empower healthcare providers [4][5] - Element5's Agentic AI transforms workflow efficiency by integrating business rules, intelligence, tools, and advanced orchestration [2][3] - The collaboration sets benchmarks for operational excellence, enabling agencies to navigate current challenges and expand in the healthcare sector [5]

Core Insights - Tempus AI's stock surged nearly 14% following FDA clearance for its upgraded cardiac imaging platform, Tempus Pixel, significantly outperforming the S&P 500's 0.9% increase on the same day [1][2]. Regulatory Approval - The U.S. FDA granted clearance for Tempus Pixel, which utilizes AI technology to generate highly accurate cardiac images, marking a significant regulatory milestone for the company [2][3]. Product Impact - The upgraded Tempus Pixel is expected to enhance both the company's financial performance and contribute positively to medical science, as stated by Chris Scotto Divetta, the senior vice president of AI applications at Tempus AI [3]. Product Portfolio Expansion - Tempus AI is diversifying its offerings beyond cardiac imaging, providing AI-enhanced analytical tools for diagnostics such as CT scans and X-rays, positioning itself as a leader in the effective application of AI in healthcare [4].

Group 1 - Tempus AI Inc. is considered one of the least favorable AI stocks to invest in according to financial media [1] - An expanded collaboration between Northwestern Medicine and Tempus AI was announced, marking Northwestern Medicine as the first health system to integrate Tempus' generative AI-enabled clinical assistant, David, into its electronic health record (EHR) platform [1][2] - The partnership aims to enhance patient care by utilizing data and AI, building on a decade-long collaboration [2] Group 2 - The integration of David will provide Northwestern Medicine's clinical teams with real-time AI-enabled insights directly within the EHR [2][3] - By adopting Tempus' AI infrastructure, Northwestern Medicine will support its AI applications with a multimodal patient record, facilitating the co-development and real-time monitoring of new AI algorithms [3] - Clinical teams will be able to perform various functions, including building custom AI agents, querying patient data using natural language, and automating pre-appointment preparations with AI-generated summaries [3] Group 3 - Tempus AI Inc. specializes in healthcare technology, offering next-gen sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other pathology testing [4] - While there is potential for investment in Tempus AI, other AI stocks are viewed as having greater upside potential and lower downside risk [5]

Core Insights - Claritev Corporation has been certified as a Great Place To Work® for the fourth consecutive year, highlighting its commitment to employee satisfaction and workplace culture [1] Employee Satisfaction - 76% of employees reported that Claritev is a great place to work, which represents a 19-point increase from previous assessments [1]

Core Insights - Medical Care Technologies Inc. (MDCE) is enhancing its balance sheet through its subsidiary Infinite Auctions LLC, which has acquired a significant inventory of sports memorabilia and trading cards valued at approximately $2.54 million [1] Group 1: Company Developments - Infinite Auctions LLC has amassed a sports memorabilia and trading card inventory, including high-value items such as a LeBron James 2016 NBA Finals game-worn jersey and a rare Tom Brady 1/1 card [1] - The valuation of the inventory is based on recent comparisons and fair market valuations, indicating a strategic move to leverage high-value assets for financial growth [1] Group 2: Financial Implications - The acquisition of the sports memorabilia and trading card inventory is aimed at bolstering MDCE's balance sheet, which will facilitate the acceleration of its AI health platform development [1]

Core Insights - Amesite Inc. reported a 63% revenue growth for its NurseMagic™ platform following the launch of its census-based Enterprise subscription model on July 14, 2025, with Enterprise sales now surpassing B2C sales, indicating increased demand from post-acute care providers [1] - The company is addressing the upcoming regulatory changes from the Centers for Medicare & Medicaid Services (CMS) that will increase documentation burdens, with its AI-powered HOPE automation solution designed to streamline compliance and reimbursement processes [2][3] Company Overview - Amesite Inc. is focused on transforming the $330 billion home and healthcare segments with its AI-driven solutions, particularly the NurseMagic™ platform, which reduces healthcare documentation time from 20 minutes to just 20 seconds [5] - The platform is utilized by over 100 professions and is designed to enhance operational efficiency while ensuring compliance with HIPAA regulations [5] Market Dynamics - The post-acute care market is growing at a compound annual growth rate (CAGR) of 8%, outpacing the acute care market, which presents significant opportunities for companies like Amesite [3] - The total addressable market for Amesite's solutions is expanding as the company shifts its focus from individual employees to serving entire healthcare organizations, leveraging AI technology as a competitive advantage [2]

Core Insights - Medical Care Technologies, Inc. (MDCE) reported a significant revenue generation of $1,012,019 from its subsidiaries, Infinite Auctions and Real Game Used (RGU), prior to the close of Q3 2025 [1] Financial Performance - The combined revenue of $1,012,019 indicates a strong financial performance for MDCE's subsidiaries, contributing positively to the overall balance sheet [1] Strategic Development - The revenue generated will support the development of AI-powered healthcare applications, highlighting the company's focus on innovation in health screening technologies [1]